Author:
Ikeda Shiori,Ikeda Ai,Yamagishi Kazumasa,Muraki Isao,Matsumura Takumi,Kihara Tomomi,Sankai Tomoko,Takada Midori,Okada Takeo,Kiyama Masahiko,Imano Hironori,Iso Hiroyasu,Tanigawa Takeshi
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, et al. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J. 2005;26(9):890–6.
2. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120(22):2177–87.
3. Marques LR, Diniz TA, Antunes BM, Rossi FE, Caperuto EC, et al. Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol. Front Physiol. 2018;9:526.
4. Guo X, Ma L. Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. Coron Artery Dis. 2023;34(1):66–77.
5. Soo J, Kubzansky LD, Chen Y, Zevon ES, Boehm JK. Psychological well-being and restorative biological processes: HDL-C in older English adults. Soc Sci Med. 2018;209:59–66.